E.A. Sween Company has initiated a recall of its Deli Express® BBQ Pulled Pork sandwiches after…
Category: Regulatory Affairs
Global updates on medical device regulation and quality.
FDA Alert: Purity Products Recalls ‘MyBladder’ Supplement Over Potential E. coli Contamination
On October 27, 2025, Purity Products, based in Plainview, NY, issued a voluntary recall of one…
FDA Grants Emergency Use Authorization for Screwworm Treatment in Dogs
The U.S. Food and Drug Administration (FDA) has taken an important regulatory step to address New…
Health Canada Shares Stakeholder Feedback on Co-Packaged Drug Products Guidance
Health Canada has released insights on stakeholder feedback regarding its draft guidance for co-packaged drug products,…
Swissmedic Expands Therapeutic Indication for Palforzia®
Swissmedic, Switzerland’s agency for the authorization and supervision of therapeutic products, has announced an extension of…
Swissmedic Announces Authorization of Ayvakyt®: A Clinical Update
Swissmedic, the Swiss agency for therapeutic products, has announced the first regulatory authorization for Ayvakyt®. This…
Swissmedic Grants Initial Authorization for Wainzua®: Key Regulatory Update
Swissmedic, the Swiss agency responsible for licensing and monitoring therapeutic products, has announced the initial authorization…
Tamsulosin and Its Association with Intraoperative Floppy Iris Syndrome: Swissmedic Insights
Swissmedic has issued an important notice about the risks of intraoperative floppy iris syndrome (IFIS) among…
Swissmedic Updates on Veterinary Drug Reactions: Key Insights from 2024 Reports
The latest vigilance report from Swissmedic highlights significant findings regarding adverse reactions to veterinary medicinal products…
Swissmedic Advisory: Reduced Shelf Life for Lecigon (Carbidopa/Entacapone/Levodopa)
Swissmedic has issued a health professional communication regarding a change in the shelf life of Lecigon,…